*Streptococcus pneumoniae* is the most common cause of bacterial pneumonia in children contributing to the high percentage of morbidity and mortality worldwide. Pneumococcal pneumonia is highly associated with high mortality rate of children below five years old, particularly in the developing countries[@ref1]. Increasing incidence of antibiotic resistance in *S. pneumoniae* strains worldwide is imposing challenges for the effective treatment of *S. pneumoniae* infections[@ref2]. Penicillin has been used as the primary antibiotic to treat *S. pneumoniae* infections. However, the widespread use of penicillin has instigated the emergence of penicillin-resistant *S. pneumoniae* strains, driving the needs for alternative treatment of the diseases[@ref2]. Since prevalence and distribution of penicillin-resistant strains differ geographically[@ref3], surveillance and continual monitoring of penicillin susceptibility among the local *S. pneumoniae* strains is important.

*S. pneumoniae* can be classified into \>90 distinct serotypes based on its reaction with type-specific antisera against the capsular polysaccharides. *S. pneumoniae* serotypes vary in invasiveness, virulence and antibiotic resistance. Differential ability of the serotypes to cause invasive diseases is dependent on the chemical structure of the capsular polysaccharides and rarely the thickness of the capsules[@ref1]. Serotypes that are associated with invasive pneumococcal diseases (IPD) among children, such as 19A, 3, 7F, 23F, 11, 6A, 6B, 14, 8, 18C and 19F have been described previously[@ref4][@ref5][@ref6]. Among these common serotypes in children, serotypes 19A, 3, 7F, 23F, 14 and 8 were also present in adults[@ref5][@ref6].

Precise and accurate serotyping is essential in the epidemiological study of *S. pneumoniae* and its serotypes. Several serotyping methods have been introduced to deduce the serotypes of *S. pneumoniae* including Quellung test which is the gold standard technique[@ref7]. Unfortunately, this test is time-consuming and requires interpretation expertise. To overcome these problems, latex agglutination tests and counterimmunoelectrophoresis were introduced[@ref8][@ref9]. Later on, PCR-based assays became preferable over the conventional methods. PCR-based serotyping assays are designed to identify serotype-specific target sequences within the pneumococcal capsular gene cluster to deduce the *S. pneumoniae* serotypes[@ref10].

Capsular polysaccharides as the major virulence factor of *S. pneumoniae* are also used as immunogens in pneumococcal vaccines. *S. pneumoniae* infections are preventable by vaccination. In Malaysia, the pneumococcal vaccines are not included in the National Childhood Immunisation programme[@ref11]. However, continuous surveillance on the diversity, prevalence and penicillin susceptibility of the *S. pneumoniae* serotypes are vital to enhance the existing vaccination and treatment protocols[@ref5]. Therefore, this study was aimed to report on the diversity, occurrence and penicillin susceptibility of *S. pneumoniae* serotypes among paediatric patients in a tertiary care teaching hospital in Malaysia.

Material & Methods {#sec1-1}
==================

The study was approved by the Medical Ethics Committee of University Malaya Medical Center (UMMC) (MECID: 20146-336), Kuala Lumpur, Malaysia. Electronic medical records were reviewed to obtain patients' characteristics (age, gender, ethnicity and source of isolates) and penicillin susceptibility data (penicillin-susceptible, intermediate or resistant).

*Bacterial isolates*: One hundred and twenty five *S. pneumoniae* isolates were collected from Medical Microbiology Laboratory, UMMC. The isolates were previously isolated from respiratory tract clinical specimens from all paediatric patients (age ranged from one month to 12 yr) admitted to UMMC from January 2013 to May 2015. The source of the isolates included nasopharyngeal specimens (NPS), sputum and bronchoalveolar lavage (BAL, mini-BAL). Clinical specimens were cultured and subjected to identification using VITEK 2 system (bioMérieux, Inc., Hazelwood, Mo., USA). The confirmed *S. pneumoniae* isolates were cryopreserved. To revive the isolates, 100 μl of the stock was suspended in 400 μl of brain heart infusion broth and incubated overnight at 37°C with 5 per cent CO~2~. One loopful of the overnight culture was streaked on sheep blood agar and further incubated under the same conditions.

*Genomic DNA extraction*: The extraction of DNA was performed by boiling lysis of bacteria as described by Yap *et al*[@ref12] with slight modification. Briefly, countable α-haemolytic *S. pneumoniae* colonies were picked from blood agar plate, and washed with phosphate buffered saline. The cells were centrifuged for 10 min at 11,337× g. The supernatant was eliminated and the pellet was re-suspended in 100 μl of ultrapure water, subjected to boiling at 99°C in a water bath for 10 min, cooled on ice for five minutes and stored at −20°C until further use.

*PCR confirmation of *Streptococcus pneumoniae* and capsular typing*: PCR was performed to reconfirm the identity of the revived culture prior to capsular typing of *S. pneumoniae* isolates. Primers targeting transketolase (*RecP*), a housekeeping gene of *S. pneumoniae* as described by Enright and Spratt[@ref13] were used for PCR confirmation of *S. pneumoniae*. PCR was performed in a final reaction volume of 25 μl comprising 0.5 U of *Taq* polymerase (Promega, Madison, USA), 1.5 mM MgCl~2~, 1× buffer, 0.2 mM of deoxynucleotide triphosphates (dNTPs), 0.4 mM of primers RecP-f and RecP-r and 100 ng of genomic DNA. PCR amplifications were carried out in a Veriti^®^ Thermal Cycler (Applied Biosystems, USA) using the following cycling conditions: 94°C for five min and 30 cycles of 94°C for 15 sec, 50°C for 30 sec and 72°C for 45 sec. Following amplification, all reactions were extended at 72°C for 10 min.

Capsular typing was carried out using 30 serotype specific primer pairs[@ref14][@ref15][@ref16][@ref17]. Primer sequences and PCR protocols of the capsular typing assay were obtained from the previous study[@ref18]. Briefly, primers with varying concentrations were grouped into seven multiplex reactions to allow differentiation of PCR products based on respective band sizes. Each reaction comprised five to six primer pairs targeting respective serotypes including a primer targeting the *CpSA* gene, a conserved region located at the cps locus that served as an internal control. PCR reactions were performed in a 25 μl reaction mixture comprising 0.5 U of *Taq* polymerase, 1.5 mM MgCl~2~, 1× buffer, 0.2 mM of dNTPs and 100 ng/μl of genomic DNA. PCR amplifications were carried out in a Veriti^®^ Thermal Cycler using the following cycling conditions: 94°C for four min and 30 cycles of 94°C for 45 sec, 54°C for 45 sec and 65°C for two min and 30 sec without extension.

Four microliters of PCR products obtained from both molecular identification and capsular typing assays were analyzed on one per cent LE agarose gel electrophoresis (Promega, Madison, USA) and stained with SYBR^®^ Safe DNA Gel Stain (Invitrogen Corporation, USA). A100 bp DNA ladder was included in all gels. The gels with resulting bands were viewed under an ultraviolet transilluminator.

*Statistical analysis*: Statistical analysis was performed using IBM SPSS Modeller v.16 software (IBM Corp, Armonk, New York, USA). Random Forest analysis was used to study the relationship between serotype frequency and patient demographics.

Results {#sec1-2}
=======

The patients belonged to four ethnic groups (Malay, Chinese, Indian and others) and categorized into two major age categories (\<5 yr old, n=115 and \>5 yr old, n=10). Majority (92.0%) of the patients were below five years while only 8.0 per cent were above five years. Most (n=113, 90.4%) of the isolates were isolated from NPS. The remaining isolates were isolated from sputum (n=6, 4.8%), nasal swabs (n=1, 0.8%), BAL (n=2, 1.6%) and mBAL (n=3, 2.4%).

*RecP PCR-screening and multiplex capsular typing*: Prior to serotyping, identity of all the isolates was re-confirmed by PCR targeting *RecP* gene and all were found to be *RecP* positive. Based on multiplex PCR serotyping, 10 serotypes representing eight different serogroups were determined among the 125 isolates ([Figure](#F1){ref-type="fig"}). Only 96 isolates (76.8%) were serotyped; 29 isolates (23.2%) were categorized as non-typeable (NT) by the multiplex PCR used in the study. All isolates were *CpsA* positive including the NT isolates. Majority of our isolates belonged to serotype 19F (25.6%), followed by serotypes 6A/B (23.2%), 23F (8.8%), 6C (4.8%), 23A (4.0%), 11A/D/F (3.2%), 19A (3. 2%), 34 (1.6%), 3 (1.6%) and 15A/F (0.8%).

![Serotype diversity of *Streptococcus pneumoniae* isolates isolated from paediatric patients (January 2013 to May 2015).](IJMR-148-225-g001){#F1}

Thirty three *S. pneumoniae* isolated in 2013 were represented by eight serotypes (3, 6A/B, 6C, 11A/D/F, 19A, 19F, 23A and 23F). In 2014, the 56 *S. pneumoniae* isolates comprised of seven serotypes (6A/B, 6C, 11A/D/F, 19A, 19F, 23F and 34). In 2015 between January and May, 10 serotypes (3, 6A/B, 6C, 11A/D/F, 15A/F, 19A, 19F, 23A, 23F and 34) were identified among the 36 *S. pneumoniae* isolates. The diversity and percentage of distribution of serotypes were different each year. However, serotypes 19F and 6A/B were consistently prevalent between January 2013 and May 2015.

*Penicillin susceptibility*: Penicillin susceptibility patterns of the 124 *S. pneumoniae* isolates were gathered from the electronic records and tabulated with respect to the serotypes ([Table I](#T1){ref-type="table"}). One isolate was excluded from the penicillin susceptibility analysis due to the absence of required information on the system. *S. pneumoniae* isolates were categorized based on their susceptibility to penicillin namely penicillin-susceptible, penicillin intermediate and penicillin-resistant. Of the 124 *S. pneumoniae* isolates, 94.4 per cent were penicillin-susceptible, 5.6 per cent were penicillin intermediate and 2.4 per cent were penicillin-resistant. With respect to the serotype distribution, 3.4 per cent isolates of serotype 6A/B were penicillin resistant. Further, 9.4 and 3.1 per cent isolates of serotype 19F that were penicillin intermediate and penicillin-resistant, respectively. Separately, 20.0 per cent isolates of serotype 23A were penicillin intermediate while 3.6 per cent of NT isolates were penicillin resistant. Rest of the isolates were susceptible to penicillin.

###### 

Penicillin susceptibility with respect to serotype distribution of *Streptococcus pneumoniae* isolates collected from January 2013 to May 2015
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For statistical analysis, serotypes distributed with more than 10 cases (serotype 6A/B, 19F, 23F and NT) were selected for Random Forest analysis. Based on the model built using three predictors namely ethnicity, age and gender, the overall error rate of the model was high at 56.3 per cent. However, good prediction rate of 83.0 per cent was achieved for serotype 19F ([Table II](#T2){ref-type="table"}). The high prediction rate was mainly contributed by the strong correlation between serotype 19F and age ([Table III](#T3){ref-type="table"}).
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Confusion matrix generated by SPSS modeller for serotypes 6A/B, 19F, 23F and NT
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Rank of variable importance to the model generated by SPSS modeller for serotypes 6A/B, 19F, 23F and NT based on three descriptors (age, ethnicity and gender)
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Discussion {#sec1-3}
==========

Pneumonia is the major cause of morbidity and mortality in children. *S. pneumoniae* is the major causative agent of pneumonia thus imposing a serious need in understanding the epidemiology of the bacterium. There are over 90 serotypes of *S. pneumoniae* identified to date. These serotypes are known to cause distinct clinical presentations of pneumococcal diseases[@ref19]. Accurate serotyping of the bacterium is vital to study the serotype distribution and potential in causing pneumococcal diseases. The seven sequential multiplex PCRreactions for *S. pneumoniae* serotyping were previously developed by Pai *et al*[@ref10]. It was later adapted and modified in other studies to suit their objectives. For instance, the sequential multiplex PCR reactions have been modified to target only IPD-associated serotypes[@ref20]. The multiplex PCR has also been used to determine serotypes associated with pneumococcal carriage as well as IPD in some studies[@ref21]. In our study, we adapted the multiplex PCR assay described by Jourdain *et al*[@ref18] as this was a modified assay to specifically detect pneumococcal carriage associated serotypes. It is generally perceived that pneumococcal carriage precedes infections such as pneumonia and IPD. Hence, the baseline data on the prevalence and diversity of the serotypes associated with pneumococcal carriage and infections will be useful for further evaluation of pneumococcal vaccines in reducing pneumococcal diseases.

Our results suggested that serotypes 19F and 6A/B were the most prevalent serotypes. The findings were in agreement with the previous reports on the prevalence of different serotypes of *S. pneumoniae* around the world. For instance, serotype 19F and 6B were reported as two of the most common serotypes among the 171 *S. pneumoniae* isolates collected from children in China from 2006 to 2008, where 19F and 6B serotypes were commonly detected from children below five years old while serotype 19F was the predominant serotype among children above five years of age[@ref22]. In another study, serotypes 6A, 6B and 19F were reported as the common *S. pneumoniae* serotypes among 22 different serotypes detected in 367 Lithuanian children under six with serotype 6B (15.8%) as the most common serotypes detected, followed by 19F (13.9%) and 6A (9.3%) as the sixth most common serotype[@ref23]. In addition, serotypes 19F and 6B were also found to be the most common *S. pneumoniae* serotypes detected among 835 Moscowian children below six years old[@ref24]. In contrast, Rijal *et al*[@ref25] reported low distribution of serotypes 19F (2.1%) and serotype 6B (2.1%) among 60 Nepalese children. Serotypes 1 (27.7%), 5 (19.1%) and 4 (8.5%) were more common serotypes reported in the study with distribution above 5 per cent. However, serotypes 1 and 4 were not detected and serotype 5 was not targeted by the sequential multiplex PCR reactions used in our study.

In Malaysia, the most common serotypes (1, 2, 4, 6A/B, 7A/F, 7C, 9V/A, 9N/L, 11A, 14, 15/BC, 17F, 18A/B/C, 19A, 19F, 20, 23F, 23A, 23B) of *S. pneumoniae* have been identified previously[@ref26][@ref27][@ref28][@ref29][@ref30]. In 2011, serotypes 6A/6B, 11A, 15B/C, 19A, 19F, 23A and 23F were detected among 41 Malaysian isolates by Shakrin *et al*[@ref30]. Sixteen isolates (39.0%) were of serotype 6A/6B, followed by 22.0 per cent isolates of serotype 23F. Only 12.2 per cent isolates of serotype 19F were detected[@ref30]. On the other hand, serotypes of 151 *S. pneumoniae* isolates from both children and adult patients in UMMC from 1999 to 2007 have been reported[@ref29]. The strains were serotyped into different serogroups including serotypes 1, 3, 6A/B, 7C/B/40, 7F/A, 9V/A 10A, 11A/D, 12F/A, 14, 15A, 15B/C, 16F, 18C/B/A/F, 19A, 19F, 23F, 34, 35B and 35F/47F. The most prevalent serotypes among children under five were serotypes 19F (46.8%), 23F (6.4%), 1 (6.4%) and 14 (6.4%)[@ref29]. Our study results concurred with these findings[@ref29][@ref30] as serotypes 19F and 6A/B contributed \>18.0 per cent annually throughout the study. It is also noteworthy that more than six per cent of the isolates reported by Le *et al*[@ref29] belonged to serotypes 1 and 14. However, these two serotypes were not detected in our study and indicated a possibility of a shift in serotype distribution trends.

Most of our isolates (94.4%) were penicillin susceptible. Among the seven non-susceptible *S. pneumoniae* isolates, four were of serotype 19F. Although our study revealed a lower percentage of penicillin non-susceptible *S. pneumoniae* isolates compared to Le *et al*[@ref29], serotype 19F remained as the significant contributor to the rate of penicillin non-susceptible *S. pneumoniae* isolates in both studies. Desa *et al*[@ref31] reported 22.9 per cent of their *S. pneumoniae* isolates as penicillin resistant, and 18.4 per cent as penicillin intermediate.

In conclusion, our study showed the distribution of various serotypes in *S. pneumoniae* isolates from children in a teaching hospital at Malaysia with decreasing incidence of penicillin-resistant isolates. However, the association of serogroups distribution and vaccination plan was not analyzed due to the absence of clinical data and patient\'s vaccination records.
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